DEVELOPMENT OF PRODUCT CONTAINING MICROENCAPSULATED PROBIOTICS: AN UPDATE ON ISSUES
Abstract
To have a handy reference and a source of outstanding knowledge for the scientist engaged in developing products containing probiotics (PRs). Probiotic micro-organisms explored for delivering associated proclaimed valuable benefits. PRs included in the pharmaceutical, dairy, nondairy, and personal care products. The market of all these products is expanding day by day, which expected to prosper. Diverse methods and technology devised to get their product with wished and improved performances. All these methods or technologies have failed in achieving preset goal, as they could not improve their performances and marketplace survival. Microencapsulation (MEC) can achieve goals with promoted degrees of success. Interest evoke for marketing of product containing encapsulated probiotics (PCMP), as means to upkeep their performance, reproducible, throughout life cycle. Related reports are available in literatures, which are unable to provide latest information and found unhandy for professionals. In this regard, information collected from form databases and presented as a handy reference. The review features on basis, limits, and applicability of MEC method suited for evolution of PCMP. Theme of debate also covers issues on their development, evaluation, and marketing. Presented information will be a helping hand for scientists and will offer an outstanding knowledge to developers, while designing them, with excellent feature and improved marketability.DOI
https://doi.org/10.22270/jddt.v3i5.600Published
2013-09-14
Statistics
Abstract Display: 496
PDF Downloads: 699 How to Cite
1.
Alli SMA. DEVELOPMENT OF PRODUCT CONTAINING MICROENCAPSULATED PROBIOTICS: AN UPDATE ON ISSUES. J. Drug Delivery Ther. [Internet]. 2013 Sep. 14 [cited 2026 Jan. 14];3(5):121-3. Available from: https://jddtonline.info/index.php/jddt/article/view/600
Issue
Section
Review
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0). that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
How to Cite
1.
Alli SMA. DEVELOPMENT OF PRODUCT CONTAINING MICROENCAPSULATED PROBIOTICS: AN UPDATE ON ISSUES. J. Drug Delivery Ther. [Internet]. 2013 Sep. 14 [cited 2026 Jan. 14];3(5):121-3. Available from: https://jddtonline.info/index.php/jddt/article/view/600

.